Literature DB >> 17595220

Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization.

Helge Müller1, Nora Schweitzer, Olaf Jöhren, Peter Dominiak, Walter Raasch.   

Abstract

The HPA axis is hyperactive under conditions of leptin and insulin resistance as well as after ANG II administration. We hypothesized that a hyperreactivity of the HPA axis to ANG contributes to an impaired glucose utilization in obesity, since leptin resistance and an overactive renin-angiotensin-aldosterone system are features of obesity. Zucker rats were treated with ANG via subcutaneous minipumps (0, 0.9, and 9.0 mug/h; 4 wk). PA axis reactivity and glucose homeostasis were characterized after CRH treatment and during an oral glucose tolerance test (OGTT). The elevated plasma profile of corticosterone after CRH stimulation in saline-treated OZR compared with LZR confirmed that the sensitization of the PA axis depended on leptin resistance. Irrespective of the rat strain, circulating ANG levels and blood pressure were selectively increased after administration of 9 mug/h ANG (high ANG). Only high ANG induced an elevation of the corticosterone and glucose response after CRH stimulation in OZR but did not affect the ACTH secretion. During OGTT, corticosterone and consequently glucose increased in OZR after high ANG, whereas the insulin secretion was decreased. In the adrenal glands of OZR, AT(1A) receptor mRNA levels increased after high ANG. We conclude that the impairment of glucose utilization after ANG stimulation is potentiated in leptin-resistant rats as a result of a hyperreactive PA axis, thereby confirming the functional importance of a dysregulation within the HPA axis in metabolic syndrome or obesity. The ACTH-independent stimulation of corticosterone release and the selective increase of AT(1A) receptor mRNA in the adrenals of OZR indicated a sensitization of adrenals toward ANG, causing a stimulation of the PA axis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595220     DOI: 10.1152/ajpendo.00650.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.

Authors:  Martin Mildner; Helge Müller-Fielitz; Ines Stölting; Olaf Jöhren; Muscha Steckelings; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-31       Impact factor: 3.000

2.  Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

Authors:  Anja Miesel; Helge Müller-Fielitz; Olaf Jöhren; Florian M Vogt; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.

Authors:  Helge Müller-Fielitz; Margot Lau; Cathleen Geißler; Lars Werner; Martina Winkler; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

4.  Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone.

Authors:  Rudy M Ortiz; Hiroyuki Kobori; Debra Conte; L Gabriel Navar
Journal:  Growth Horm IGF Res       Date:  2010-05-18       Impact factor: 2.372

5.  Development of obesity can be prevented in rats by chronic icv infusions of AngII but less by Ang(1-7).

Authors:  Martina Winkler; Michael Bader; Franziska Schuster; Ines Stölting; Sonja Binder; Walter Raasch
Journal:  Pflugers Arch       Date:  2018-02-11       Impact factor: 3.657

6.  Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress.

Authors:  Enrique Sánchez-Lemus; Masaru Honda; Juan M Saavedra
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

7.  The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats.

Authors:  Martina Winkler; Johanna Schuchard; Ines Stölting; Florian M Vogt; Jörg Barkhausen; Christoph Thorns; Michael Bader; Walter Raasch
Journal:  Br J Pharmacol       Date:  2016-03-27       Impact factor: 8.739

8.  Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.

Authors:  Helge Müller-Fielitz; Margot Lau; Olaf Jöhren; Florian Stellmacher; Markus Schwaninger; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

9.  Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats.

Authors:  Ruben Rodriguez; Andrew Y Lee; Jose A Godoy-Lugo; Bridget Martinez; Hiroyuki Ohsaki; Daisuke Nakano; David G Parkes; Akira Nishiyama; José Pablo Vázquez-Medina; Rudy M Ortiz
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-18       Impact factor: 4.310

10.  Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.

Authors:  Helge Müller-Fielitz; Nils Hübel; Martin Mildner; Florian M Vogt; Jörg Barkhausen; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.